|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
2786858 |
003 |
ICU |
005 |
20040127084100.0 |
008 |
970605s1997 nyua b 101 0 eng d |
020 |
|
|
|a 0824798945
|
035 |
|
|
|a (OCoLC)37022192
|
040 |
|
|
|a CUI
|c CUI
|d OCL
|d VPI
|
049 |
|
|
|a CGUA
|
090 |
|
|
|a RC918.R4
|b P33 1997
|
096 |
|
|
|a WJ 342 P297 1997
|
245 |
0 |
0 |
|a Pathogenetic and therapeutic aspects of chronic renal failure /
|c edited by K.M. Koch, Günter Stein.
|
260 |
|
|
|a New York :
|b M. Dekker,
|c c1997.
|
300 |
|
|
|a xii, 242 p. :
|b ill. ;
|c 24 cm.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
500 |
|
|
|a Papers from an international workshop, "Chronic renal failure: pathogenetic and therapeutic aspects", held in Berlin in May 1996.
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|g 1.
|t Relevance of Diet in the Progression of Renal Insufficiency /
|r Saulo Klahr --
|g 2.
|t Hypertension in Progressive Renal Disease /
|r Johannes F. E. Mann, Karl F. Hilgers and Roland Veelken [et al.] --
|g 3.
|t Potential Role of Lipids in the Progression of Glomerular Diseases /
|r Christoph J. Olbricht --
|g 4.
|t Is Metabolic Acidosis a Risk Factor in the Progression of Renal Insufficiency? /
|r F. John Gennari --
|g 5.
|t Diabetic Nephropathy /
|r Trond D. Jenssen --
|g 6.
|t Etiology and Pathophysiology of Left Ventricular Hypertrophy /
|r Franz H. Messerli and Leszek Michalewicz --
|g 7.
|t Uremic Cardiomyopathy /
|r Eberhard Ritz, Ute Schwartz and Michael Rambausek [et al.] --
|g 8.
|t Microalbumin and Cardiovascular Risk in Hypertension /
|r Bhuwnesh Agrawal and Friedrich C. Luft --
|g 9.
|t Improvement of Coronary Microcirculation by ACE Inhibitors /
|r S. Scheler, W. Motz and B. E. Strauer --
|g 10.
|t Dialysis Regimens and Myocardial Hypertrophy /
|r W. H. M. van Kuijk, A. J. Luik and K. M. L. Leunissen --
|g 11.
|t Evidence-Based Recommendations for the Clinical Use of rhEPO /
|r N. Muirhead --
|g 12.
|t Analysis of Safety Database for Long-Term Epoetin-[beta] Treatment: A Meta-Analysis Covering 3697 Patients /
|r J. Mocks, W. Franke and B. Ehmer [et al.] --
|g 13.
|t Iron Therapy: Overview and Recommendations /
|r Iain C. Macdougall --
|g 14.
|t Continuous Administration of Intravenous Iron During Hemodialysis /
|r C. Granolleras, A. Zein and R. Oules [et al.] --
|g 15.
|t Erythropoietin and Kidney Transplantation /
|r R. Vanholder and A. Van Loo --
|g 16.
|t Effects of rhEPO on Regulation of Pulsatile Gonadotropin Secretion /
|r Franz Schaefer, Birgit van Kaick and Gunter Stein [et al.] --
|g 17.
|t Anemia Correction and Cardiac Function: Coronary Artery Disease and Left Ventricular Hypertrophy /
|r V. Wizemann.
|
650 |
|
0 |
|a Chronic renal failure.
|0 http://id.loc.gov/authorities/subjects/sh85112814
|
650 |
|
7 |
|a Chronic renal failure.
|2 fast
|0 http://id.worldcat.org/fast/fst00860126
|
700 |
1 |
|
|a Koch, K. M.
|0 http://id.loc.gov/authorities/names/n85819885
|1 http://viaf.org/viaf/17615496
|
700 |
1 |
|
|a Stein, Günter,
|c M.D.
|0 http://id.loc.gov/authorities/names/n97802580
|1 http://viaf.org/viaf/70685641
|
901 |
|
|
|a ToCBNA
|
903 |
|
|
|a HeVa
|
929 |
|
|
|a cat
|
999 |
f |
f |
|i 6a3afdf4-5a04-5ebe-a33b-c5236ee3824f
|s 4ed7c370-d3a0-56a5-ab5a-0eb78dc86435
|
928 |
|
|
|t Library of Congress classification
|a RC918.R4 P38 1997
|l ASR
|c ASR-SciASR
|i 3267648
|
927 |
|
|
|t Library of Congress classification
|a RC918.R4 P38 1997
|l ASR
|c ASR-SciASR
|e BELF
|e CRERAR
|b 47492746
|i 5044738
|